Investors

Pressure BioSciences Inc.

Pressure BioSciences, Inc. ("PBI") (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. Customers also use our products in other areas, such as bio-therapeutics characterization, soil & plant biology, vaccine development, and counter-bioterror applications.

Download Executive Summary

Download Tear Sheet

 

 PBI Logo  PBI Logo

SEC 10 K Picture

 

SEC 10 Q Picture

Corporate Presentation

SNNLive Video Interview Q1 2016 Update with Mr. Richard T. Schumacher (CEO & Founder)

10-K – Dec 31, 2015

10-Q – Mar 31, 2015

 

Investor Relations Transfer Agent Auditors Corporate Counsel

Richard T. Schumacher
CEO & Founder 
Pressure BioSciences, Inc.
14 Norfolk Avenue
South Easton, MA 02375
This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: (508) 230-1828
Fax: (508) 230-1829

Computershare Trust Company, Inc.
350 Indiana Street, Suite 800
Golden, CO 80401
Telephone: (303) 262-0600

MaloneBailey LLP
9801 Westheimer Road
Suite 1100
Houston, TX 77042
P: 713.343.4286

Lucosky Brookman LLP 
101 Wood Avenue South
Woodbridge, New Jersey 08830
Tel 732 395 4400
Fax 732 395 4401